Volume limiting chamber

Claim 2

A volume limiting chamber for use in an intravenous set comprising a chamber having a top and a bottom and side walls connecting said top and bottom, an inlet passageway in said top for placing said chamber in fluid communication with a source of parenteral solution, an outlet passageway in said bottom for placing said chamber in fluid communication with an intravenous needle, indicia on said chamber for indicating the amount of parenteral solution in said chamber, a membrane valve positioned in said chamber and cooperating with said outlet fluid passageway so that all parenteral solution in said chamber flows through said membrane valve, said membrane valve comprising a material which when wet will pass parenteral fluid but will not pass air at normal intravenous administration pressures, and means for bypassing said membrane valve, said means allowing air to enter said chamber through said bottom from underneath said membrane valve when said membrane valve is wet.

Claim 3

The volume limiting chamber of claim 1 in which said bypass means comprises means for mounting said membrane valve in said bottom so that air can enter said volume limiting chamber around the periphery of said membrane valve.

Claim 4

The volume limiting chamber of claim 2 in which said mounting means comprises a surface against which said membrane valve is adapted to seat, said surface having a plurality of air passages formed therein in communication with said outlet passageway such that air forced through said outlet passageway and said air passages will act to unseat said membrane valve.

Claim 5

The volume limiting chamber of claim 3 in which said mounting means further comprises a bypass member spaced from said surface to define a membrane valve chamber therebetween, said membrane valve being mounted in said membrane valve chamber.

Claim 6

The volume limiting chamber of claim 4 in which said bypass member has air passages communicating with said membrane valve chamber and the interior of said volume limiting chamber.

Claim 7

The volume limiting chamber of claim 5 in which said air passages in said bypass member comprise an annular groove positioned adjacent the outer peripheral surface of said membrane valve and a plurality of radially extending passages connecting with said annular groove.

Claim 8

The volume limiting chamber of claim 6 in which said bypass member has upper and lower surfaces and said plurality of radially extending passages comprise a plurality of radially extending grooves in said lower surface of said bypass member communicating directly with said annular groove and a plurality of radially extending slots in said upper surface of said bypass member communicating directly with said radially extending grooves.

Claim 9

The volume limiting chamber of claim 3 in which said plurality of air passages comprise concentric grooves formed in said surface of said mounting means.

Claim 10

The volume limiting chamber of claim 1 in which said bypass means comprises an air passageway in said bottom and check valve means associated with said air passageway for allowing air to enter said chamber through said air passageway and preventing parenteral solution from exiting said chamber through said air passageway.

Claim 11

The volume limiting chamber of claim 9 in which said check valve means comprises a segment of elastomeric tubing.

Claim 12

The volume limiting chamber of claim 10 in which said segment of elastomeric tubing comprises a segment of silicone rubber tubing having a slit formed therein.

Claim 13

An intravenous set comprising a volume limiting chamber for controlling the volume of parenteral solution administered to a patient and a flexible drip chamber for determining the parenteral solution flow rate positioned downstream of said volume limiting chamber, said volume limiting chamber including a top and bottom and side walls connecting said top and bottom, an inlet passageway in said top for placing said volume limiting chamber in fluid communication with a source of parenteral solution, an outlet passageway in said bottom for placing said volume limiting chamber in fluid communication with said drip chamber, indicia on said volume limiting chamber for indicating the amount of parenteral solution in said volume limiting chamber, a membrane valve positioned in said bottom of said volume limiting chamber and cooperating with said outlet passageway so that all parenteral solution in said volume limiting chamber flows through said membrane valve, said membrane valve comprising a material which when wet will pass parenteral solution but will not pass air at normal intravenous administration pressures, and means for bypassing said membrane valve and allowing air to enter said volume limiting chamber from said drip chamber when said membrane valve is wet and said drip chamber is squeezed.

Claim 14

An intravenous set comprising a volume limiting chamber for controlling the volume of parenteral solution administered to a patient and a flexible drip chamber for determining the parenteral solution flow rate positioned downstream of said volume limiting chamber, said volume limiting chamber including a top and bottom and side walls connecting said top and bottom, an inlet passageway in said top for placing said volume limiting chamber in fluid communication with a source of parenteral solution, an outlet passageway in said bottom for placing said volume limiting chamber in fluid communication with said drip chamber, indicia on said volume limiting chamber for indicating the amount of parenteral solution in said volume limiting chamber, a membrane valve positioned in said bottom of said volume limiting chamber and cooperating with said outlet passageway so that all parenteral solution in said volume limiting chamber flows through said membrane valve, said membrane valve comprising a material which when wet will pass parenteral solution but will not pass air at normal intravenous administration pressures, and means for bypassing said membrane valve and allowing air to enter said volume limiting chamber from said drip chamber when said membrane valve is wet and said drip chamber is squeezed.

Claim 15

The intravenous set of claim 12 in which said bypass means comprises means for mounting said membrane valve in said bottom so that air can enter said volume limiting chamber around the periphery of said membrane valve.

Claim 16

The intravenous set of claim 13 in which said mounting means comprises a surface against which said membrane valve is adapted to seat, said surface having a plurality of air passages formed therein in communication with said outlet passageway such that air forced through said outlet passageway and said air passages will act to unseat said membrane valve.

Claim 17

The intravenous set of claim 14 in which said mounting means further comprises a bypass member spaced from said surface to define a membrane valve chamber therebetween, said membrane valve being mounted in said membrane valve chamber.

Claim 18

The intravenous set of claim 15 in which said bypass member has air passages communicating with said membrane valve chamber and the interior of said volume limiting chamber.

Claim 19

The intravenous set of claim 16 in which said air passages in said bypass member comprise an annular groove positioned adjacent the outer peripheral surface of said membrane valve and a plurality of radially extending passages connecting with said annular groove.

Claim 20

The intravenous set of claim 17 in which said bypass member has upper and lower surfaces and said plurality of radially extending passages comprise a plurality of radially extending grooves in said lower surface of said bypass member communicating directly with said annular groove and a plurality of radially extending slots in said upper surface of said bypass member communicating directly with said radially extending grooves.

Claim 21

The intravenous set of claim 14 in which said plurality of air passages comprise concentric grooves formed in said surface of said mounting means.

Claim 22

The intravenous set of claim 12 in which said bypass means comprises an air passageway in said bottom and check valve means associated with said air passageway for allowing air to enter said chamber through said air passageway and preventing parenteral solution from exiting said chamber through said air passageway.

Claim 23

The intravenous set of claim 20 in which said check valve means comprises a segment of elastomeric tubing.

Claim 24

The intravenous set of claim 21 in which said segment of elastomeric tubing comprises a segment of silicone rubber tubing having a slit formed therein.

Claim 25

A valve for use in an intravenous set comprising a membrane which when wet will pass parenteral fluid but will not pass air at normal intravenous administration pressures and means for mounting said membrane so that air can bypass said membrane when wet, said mounting means comprising a surface against which said membrane is adapted to seat with an airtight seal, said surface having air passage means formed therein such that air forced through said air passage means will unseat said membrane, said mounting means further comprising means for restraining the movement of said membrane when unseated.

Claim 26

A valve for use in an intravenous set comprising a membrane which when wet will pass parenteral fluid but will not pass air at normal intravenous administration pressures and means for mounting said membrane so that air can bypass said membrane when wet, said mounting means comprising a surface against which said membrane is adapted to seat with an airtight seal, said surface having air passage means formed therein such that air forced through said air passage means will unseat said membrane, said mounting means further comprising means for restraining the movement of said membrane when unseated.

Claim 27

The valve of claim 23 in which said restraining means comprises a bypass member spaced from said surface to define a membrane chamber therebetween, said membrane being mounted in said membrane chamber.

Claim 28

The valve of claim 24 in which said bypass member has air passages communicating with said membrane chamber.

Claim 29

The valve of claim 25 in which said air passages in said bypass member comprise an annular groove positioned adjacent the outer peripheral surface of said membrane and a plurality of radially extending passages connecting with said annular groove.

Claim 30

The valve of claim 26 in which said bypass member has upper and lower surfaces and said plurality of radially extending passages comprise a plurality of radially extending grooves in said lower surface of said bypass member communicating directly with said annular groove and a plurality of radially extending slots in said upper surface of said bypass member communicating directly with said radially extending grooves.

Claim 31

The valve of claim 23 in which said air passage means comprise a plurality of concentric grooves formed in said surface of said mounting means against which said membrane is adapted to seat.

Claim 32

A filter for use in an intravenous set comprising a membrane which will filter parenteral fluid and means for housing said membrane including a surface against which said membrane when wet is adapted to seat with an airtight seal at normal intravenous administration pressures, said housing means further comprising means for restraining the movement of said membrane when unseated so that said membrane is confined adjacent to said surface, said membrane being unattached to said housing means.

Claim 33

A filter for use in an intravenous set comprising a membrane which will filter parenteral fluid and means for housing said membrane including a surface against which said membrane when wet is adapted to seat with an airtight seal at normal intravenous administration pressures, said housing means further comprising means for restraining the movement of said membrane when unseated so that said membrane is confined adjacent to said surface, said membrane being unattached to said housing means.

Claim 34

The filter of claim 29 in which said restraining means comprise a member spaced from said surface to define a membrane chamber therebetween, said membrane being confined in said membrane chamber.

Claim 35

The filter of claim 29 in which said membrane when wet will pass parenteral fluid but will not pass air at normal intravenous administration pressures.

Claim 36

The filter of claim 31 in which said membrane has a mean pore size of about 0.8 to 5 microns.

Claim 37

The filter of claim 31 in which said membrane when wet is more dense than said parenteral fluid.

Claim 38

The filter of claim 29 in which said membrane comprises mixed esters of cellulose.

Claim 39

The valve of claim 23 in which said membrane comprises mixed esters of cellulose.

Claim 40

An intravenous set comprising a volume limiting chamber for controlling the volume of parenteral solution administered to a patient and a flexible drip chamber for determining the parenteral solution flow rate positioned downstream of said volume limiting chamber, said volume limiting chamber including a top and bottom and side walls connecting said top and bottom, an inlet passageway in said top for placing said volume limiting chamber in fluid communication with a source of parenteral solution, an outlet passageway in said bottom for placing said volume limiting chamber in fluid communication with said drip chamber, indicia on said volume limiting chamber for indicating the amount of parenteral solution in said volume limiting chamber, a membrane valve positioned adjacent to said outlet passageway and cooperating with said outlet passageway so that all parenteral solution in said volume limiting chamber flows through said membrane valve, said membrane valve comprising a material which when wet will pass parenteral solution but will not pass air at normal intravenous administration pressures, and means for bypassing said membrane valve and allowing air to enter said volume limiting chamber from said drip chamber when said membrane valve is wet and said drip chamber is squeezed.

Claim 41

An intravenous set comprising a volume limiting chamber for controlling the volume of parenteral solution administered to a patient and a flexible drip chamber for determining the parenteral solution flow rate positioned downstream of said volume limiting chamber, said volume limiting chamber including a top and bottom and side walls connecting said top and bottom, an inlet passageway in said top for placing said volume limiting chamber in fluid communication with a source of parenteral solution, an outlet passageway in said bottom for placing said volume limiting chamber in fluid communication with said drip chamber, indicia on said volume limiting chamber for indicating the amount of parenteral solution in said volume limiting chamber, a membrane valve positioned adjacent to said outlet passageway and cooperating with said outlet passageway so that all parenteral solution in said volume limiting chamber flows through said membrane valve, said membrane valve comprising a material which when wet will pass parenteral solution but will not pass air at normal intravenous administration pressures, and means for bypassing said membrane valve and allowing air to enter said volume limiting chamber from said drip chamber when said membrane valve is wet and said drip chamber is squeezed.